Condition

Pulmonary Hypertension clinical trials and research

As of November 12, 2026, Find a Trial lists 97 Pulmonary Hypertension clinical trials that are recruiting, at sites in 39 countries (most in United States (43), China (19), Germany (10)). 1 was first registered in the last 30 days. By phase: Phase 2 (8), Phase 3 (5), Phase 1 (3), Phase 1/2 (2). The most active sponsors are Mayo Clinic (4), Chinese Pulmonary Vascular Disease Research Group (4), University of Giessen (3). There are also 151 NIH-funded research projects on Pulmonary Hypertension, with $74.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Pulmonary Hypertension clinical trials

StudyPhaseWhereStatusRegistered
Levosimendan to see if it helps the heart after PEA in CTEPH — Novosibirsk Recruiting Nov 4, 2026
Early treatment with inhaled treprostinil for exercise-induced pulmonary hypertension in ILD or CTD Early Phase 1 Paramus, New Jersey and 1 other locations Recruiting Sep 24, 2026
Brazilian Portuguese version of EmPHasis-10 for pulmonary hypertension — Porto Alegre Recruiting Sep 16, 2026
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients Phase 3 Kissimmee, Florida and 2 other locations Recruiting Sep 11, 2026
Pulmonary Artery Denervation for Pulmonary Hypertension After M-TEER Early Phase 1 Xiamen, Fujian Recruiting Jun 23, 2026
Risk Factor Assessment for Acute Pulmonary Hypertension Crisis — Guangzhou, Guangdong and 3 other locations Recruiting Jun 17, 2026
PH Biorepository for Translational Research — Baltimore, Maryland and 2 other locations Recruiting Jun 15, 2026
Right‑side heart response to exercise in people with COPD — Aurora, Colorado Recruiting May 8, 2026
Pulmonary hypertension in adults on chronic hemodialysis: prevalence, causes, and prognosis — Pavia, Lombardy Recruiting May 4, 2026
Nicotinamide riboside for combined pulmonary hypertension — Nashville, Tennessee Recruiting May 4, 2026

All recruiting trials (97)

NIH-funded research (newest 40 of 151)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

Related topics

Cardiovascular DiseasesInterstitial Lung DiseaseHeart FailurePulmonary Arterial HypertensionVascular DiseasesChronic Kidney DiseaseFibrosisHeart Failure With Preserved Ejection FractionHypertensionInterstitial Lung Disease (ILD)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)ACS (Acute Coronary Syndrome)Adult Congenital Heart DiseaseAllogeneic Hematopoietic Stem Cell Transplantation

Quick answers

How many Pulmonary Hypertension clinical trials are recruiting right now?

97, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 39 countries. The most sites are in United States (43 trials), China (19 trials), Germany (10 trials), United Kingdom (7 trials), Czechia (5 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 8, Phase 3: 5, Phase 1: 3, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.